Long-term (3-year) neurocognitive effectiveness of antipsychotic medications in first-episode non-affective psychosis: a randomized comparison of haloperidol, olanzapine, and risperidone

被引：0
|
作者：
Rosa Ayesa-Arriola
Jose Manuel Rodríguez-Sánchez
Rocío Pérez-Iglesias
Roberto Roiz-Santiáñez
Obdulia Martínez-García
Jose Sánchez-Moreno
Rafael Tabarés-Seisdedos
Jose L. Vázquez-Barquero
Benedicto Crespo-Facorro
机构：
[1] University of Cantabria,Department of Psychiatry, Marqués de Valdecilla University Hospital, IFIMAV, School of Medicine
[2] Centro Investigación Biomédica en Red Salud Mental (CIBERSAM),Psychosis Studies Department
[3] Institute of Psychiatry,Bipolar Disorders Unit, Hospital Clínic
[4] University of Barcelona,Department of Medicine
[5] University of Valencia,undefined
来源：
Psychopharmacology | 2013年 / 227卷
关键词：
Schizophrenia; Neurocognition; Antipsychotic treatments;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：615 / 625
页数：10
相关论文
共 50 条
  • [21] Haloperidol, risperidone and olanza first-episode non-affective psychosis Dine are similarly effective for out have differing side effects
    Barbui, Corrado
    Mule, Serena
    Cipriani, Andrea
    EVIDENCE-BASED MENTAL HEALTH, 2007, 10 (03) : 74 - 74
  • [22] Rates and predictors of relapse in first-episode non-affective psychosis: a 3-year longitudinal study in a specialized intervention program (PAFIP)
    Maria Pelayo-Teran, Jose
    Gajardo Galan, Virginia Gajardo
    de la Ortiz-Garcia de la Foz, Victor
    Martinez-Garcia, Obdulia
    Tabares-Seisdedos, Rafael
    Crespo-Facorro, Benedicto
    Ayesa-Arriola, Rosa
    EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2017, 267 (04) : 315 - 323
  • [23] Rates and predictors of relapse in first-episode non-affective psychosis: a 3-year longitudinal study in a specialized intervention program (PAFIP)
    José María Pelayo-Terán
    Virginia Gajardo Gajardo Galán
    Víctor de la Ortiz-García de la Foz
    Obdulia Martínez-García
    Rafael Tabarés-Seisdedos
    Benedicto Crespo-Facorro
    Rosa Ayesa-Arriola
    European Archives of Psychiatry and Clinical Neuroscience, 2017, 267 : 315 - 323
  • [24] Clinical effectiveness and predictors of treatment non-adherence: Comparison of olanzapine, quetiapine, and risperidone in first-episode psychosis
    McEvoy, J. P.
    Perkins, D. O.
    Gu, H.
    Hamer, R. M.
    Lieberman, J. A.
    SCHIZOPHRENIA RESEARCH, 2006, 86 : S130 - S130
  • [25] One-year, randomized, open trial comparing olanzapine, quetiapine, risperidone and ziprasidone effectiveness in antipsychotic-naive patients with a first-episode psychosis
    San, Luis
    Arranz, Belen
    Perez, Victor
    Safont, Gemma
    Corripio, Iluminada
    Ramirez, Nicolas
    Duenas, Rosa
    Alvarez, Enric
    PSYCHIATRY RESEARCH, 2012, 200 (2-3) : 693 - 701
  • [26] Predictors of neurocognitive impairment at 3 years after a first episode non-affective psychosis
    Ayesa-Arriola, Rosa
    Perez-Iglesias, Rocio
    Manuel Rodriguez-Sanchez, Jose
    Pardo-Garcia, Gema
    Tabares-Seisdedos, Rafael
    Ayuso-Mateos, Jose L.
    Vazquez-Barquero, Jose L.
    Crespo-Facorro, Benedicto
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2013, 43 : 23 - 28
  • [27] Comparison of olanzapine, quetiapine, and risperidone in first-episode psychosis: A randomized 52-week trial
    McEvoy, JP
    Lieberman, JA
    Perkins, D
    Hamer, RM
    SCHIZOPHRENIA RESEARCH, 2006, 81 : 22 - 22
  • [28] Comparison of olanzapine, quetiapine, and risperidone in first-episode psychosis: A randomized, 52-week trial
    McEvoy, J.
    Lieberman, J.
    Perkins, D.
    Gu, H.
    Hamer, R.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S271 - S271
  • [29] Comparison of atypicals in first-episode psychosis: a randomized, 52-week comparison of olanzapine, quetiapine, and risperidone
    Lieberman, J
    McEvoy, JP
    Perkins, D
    Hamer, RH
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 : S526 - S526
  • [30] A comparison of long-term outcome in first-episode schizophrenia following treatment with risperidone or a typical antipsychotic
    Malla, AK
    Norman, RMG
    Scholten, DJ
    Zirul, S
    Kotteda, V
    JOURNAL OF CLINICAL PSYCHIATRY, 2001, 62 (03) : 179 - 184
12345